The merger is complete and Arcosa shares have been delisted. Former shareholders received $150.00 per share in cash. No further trading in ACA common stock is possible. Monitor for any potential appraisal rights litigation from dissenting shareholders.
Price Chart
Executive Summary
Arcosa, Inc. (ACA) has been acquired by CRH Americas (a subsidiary of CRH plc) in an all-cash merger valued at approximately $7.5 billion. Each share of Arcosa common stock was converted into $150.00 in cash. The merger closed on October 23, 2026, resulting in the termination of Arcosa's credit agreement, delisting from NYSE and NYSE Texas, and the resignation of all prior directors and officers. The company is now a wholly owned subsidiary of CRH.
Key Facts
- Merger closed on October 23, 2026, with Arcosa surviving as a wholly owned subsidiary of CRH Americas, Inc.
- Each share of Arcosa common stock converted into $150.00 in cash, with aggregate consideration of approximately $7.5 billion.
- Stockholders approved the merger at a special meeting on September 4, 2026.
- Arcosa's $700 million revolving credit facility and $700 million term loan facility were terminated; ~$450.1 million in principal was repaid.
- Trading of Arcosa common stock on NYSE and NYSE Texas was halted prior to market open on October 23, 2026.
- All prior directors and officers resigned; directors and officers of Merger Sub became the new directors and officers.
- The company filed a Form 25-NSE with the SEC to effect delisting and deregistration under Section 12(b).
- Parent funded the merger via a $3.25 billion bridge facility and a $2.5 billion term loan facility, plus cash on hand.
Financial Impact
Aggregate cash consideration of approximately $7.5 billion paid to Arcosa shareholders and equity award holders.
Risk Factors
- Potential appraisal rights litigation from shareholders who did not vote in favor and properly exercised appraisal rights under Delaware law.
- No further public market for Arcosa common stock — liquidity event is final.
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (ACA) — Batch item 1 | 0001140361-26-040596 |
| Document: ef20084131_8k.htm | 0000876661-26-000858 |
| Document: ef20084131_ex3-1.htm | 0001140361-26-040596 |
| Document: 0001140361-26-040596-index-headers.html | 0001140361-26-040596 |
| Document: 0001140361-26-040596-index.html | 0001140361-26-040596 |
| Document: 0001140361-26-040596.txt | 0001140361-26-040596 |
| 25-NSE Filing (ACA) — Batch item 7 | 0000876661-26-000858 |
| Document: 0000876661-26-000858-index.html | 0001140361-26-040596 |
| Document: 0000876661-26-000858.txt | 0001140361-26-040596 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 25-NSE | $149.50 | awaiting T+60 | — | $149.15 (−0.23%) |
Oct 23, 2026 3d ago | 25-NSE | $149.50 | awaiting T+60 | — | $149.15 (−0.23%) |
Oct 23, 2026 3d ago | 8-K / 25-NSE | $149.50 | awaiting T+60 | — | $149.15 (−0.23%) |
Aug 25, 2026 8w ago | DEFA14A | $145.25 | awaiting T+60 | — | $149.15 (+2.69%) |
Aug 14, 2026 10w ago | Institutional Cluster | $145.01 | awaiting T+60 | — | $149.15 (+2.85%) |
Aug 5, 2026 11w ago | DEFA14A | $144.89 | awaiting T+60 | — | $149.15 (+2.94%) |
Jun 22, 2026 18w ago | DEFA14A | $144.92 $145.45 | ▲ +0.37% | ▼ −3.59% | $149.15 (+2.92%) |
Jun 22, 2026 18w ago | DEFA14A | $144.92 $145.45 | ▲ +0.37% | ▼ −3.59% | $149.15 (+2.92%) |
Jun 22, 2026 18w ago | DEFA14A | $144.92 $145.45 | ▲ +0.37% | ▼ −3.59% | $149.15 (+2.92%) |
Jun 22, 2026 18w ago | 8-K | $144.90 $145.14 | ▲ +0.17% | ▼ −1.13% | $149.15 (+2.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers